Clinical Trials Sponsored by BrePco Biopharma Limited

Total 85 results

Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Healthy Subjects

Influenza A H3N2

United Kingdom
TSH Biopharm Corporation Limited

Completed

A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency

Angina

Taiwan
Prep Biopharm Limited
Hvivo

Completed

A Study to Examine the Duration of Effect of PrEP-001 in Healthy Subjects Challenged With HRV-16

Viral Upper Respiratory Tract Infection

United Kingdom
TSH Biopharm Corporation Limited

Completed

Extended-Release RANCAD in the Patients With Stable Angina Pectoris

Stable Angina Pectoris

Taiwan
TSH Biopharm Corporation Limited

Completed

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

Essential Hypertension

Taiwan
MGB Biopharma Limited
Syneos Health

Completed

Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD

Clostridium Difficile Infection

Canada, United States
Green Signal Biopharma Private Limited

Completed

A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.

Healthy

India
Melbourne Health
Biopharmica Limited

Completed

Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia

Depth of Anaesthesia

Australia
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

Solid Tumor | Hematological Malignancies

United States
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes

Solid Tumors | Hematological Malignancies

United States
Acrotech Biopharma Inc.
Axis Clinicals Limited

Terminated

To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.

Relapsed/Refractory Solid Tumors/Hematological Malignancies

United States
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)

Peripheral T-Cell Lymphoma (PTCL)

United States
Acrotech Biopharma Inc.
Axis Clinicals Limited

Unknown

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Hematologic Diseases
Acrotech Biopharma Inc.
Axis Clinicals Limited

Completed

Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies

Refractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma

United States
I-Mab Biopharma US Limited

No longer available

Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer

Cancer

United States
I-Mab Biopharma US Limited

Completed

A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

Head and Neck Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Gastrointestinal Cancer | Ovarian Carcinoma

United States
Genor Biopharma Co., Ltd.
Hutchison Medipharma Limited

Recruiting

Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib

Metastatic Non-small Cell Lung Cancer

China
Genor Biopharma Co., Ltd.
Hutchison Medipharma Limited

Unknown

Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
M.D. Anderson Cancer Center
Lyvgen Biopharma Holdings Limited

Recruiting

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Gastric Cancer | Metastatic Uveal Melanoma | Metastatic Head and Neck Carcinoma | Metastatic Hepatocellular Carcinoma | Metastatic Ovarian Carcinoma | Metastatic Soft Tissue Sarcoma | Metastatic Esophageal | Metastatic HPV Related Solid Tumors

United States
Lyvgen Biopharma Holdings Limited
Merck Sharp & Dohme LLC

Recruiting

Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy

Cancer

United States
Pharmosa Biopharm Inc.
Novotech (New Zealand) Limited

Not yet recruiting

Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults

Pulmonary Arterial Hypertension

New Zealand
Pharmosa Biopharm Inc.
Novotech (Australia) Pty Limited

Recruiting

Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

Pulmonary Arterial Hypertension

Australia
Mycenax Biotech Inc.
TSH Biopharm Corporation Limited

Terminated

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Taiwan
OncoMed Pharmaceuticals, Inc.
Novotech (Australia) Pty Limited

Completed

A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

Australia, New Zealand, Spain
OncoMed Pharmaceuticals, Inc.
Novotech (Australia) Pty Limited

Completed

A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Australia, New Zealand, Spain
Lambda Therapeutic Research Ltd.
Intas Pharmaceutical Limited (Biopharma Division)

Recruiting

Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

India
OncoMed Pharmaceuticals, Inc.
Novotech (Australia) Pty Limited

Completed

A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

Colorectal Cancer

Australia, New Zealand
Taichung Veterans General Hospital
TSH Biopharm Corporation Limited

Completed

Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis

Rheumatoid Arthritis
MGB Biopharma Limited
Hammersmith Medicines Research; Innovate UK; Cambridge Regulatory Services; Phases... and other collaborators

Completed

Safety, Blood Levels and Effects of MGB-BP-3

Healthy
RedHill Biopharma Limited
National Cancer Institute (NCI); Duke University; Apogee Biotechnology Corporation

Terminated

ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma (ABC-103)

Multiple Myeloma

United States
RedHill Biopharma Limited
Louisiana State University Health Sciences Center in New Orleans; Apogee Biotechnology...

Withdrawn

Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma (ABC-102)

Diffuse Large B Cell Lymphoma | Kaposi Sarcoma

United States
UCB Biopharma S.P.R.L.
Pharmaceutical Research Associates; Richmond Pharmacology Limited; Eurofins; ACM... and other collaborators

Completed

Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood

Systemic Lupus Erythematosus

United Kingdom
RedHill Biopharma Limited
Medical University of South Carolina; National Cancer Institute (NCI); FDA Office... and other collaborators

Completed

ABC294640 in Treating Patients With Advanced Solid Tumors (ABC-101)

Pancreatic Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Henry M. Jackson Foundation for the Advancement...
RedHill Biopharma Limited; FHI Clinical, Inc.; Joint Program Executive Office...

Recruiting

PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19 (PROTECT-APT 1)

SARS-CoV-2

United States, Côte D'Ivoire, South Africa, Thailand
University College Cork
Institut National de la Santé Et de la Recherche Médicale, France; KU Leuven; University of Alberta and other collaborators

Terminated

Management of Hypotension In the Preterm Infant (HIP)

Hypotension | Low Blood Pressure | Intraventricular Hemorrhage of Prematurity

Canada, Ireland, Belgium, Czechia, United Kingdom

Clinical Trials Sponsored by BrePco Biopharma Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations